← Leaderboards
William F Fearon
Stanford University
$5,309,897
Attributed
$5,309,897
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $769.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,309,897 · 5
By mechanism
R01$2,488,511 · 2
R33$1,756,042 · 1
K23$629,810 · 1
R61$435,534 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Raiyan Tripti Zaman$1,582,252
- Roham Zamanian$6,654,663
- Benjamin Alan Goldstein$5,376,207
- John M. Pauly$18,804,688
- George F Van Hare$1,452,203
Others in their field
Top investigators on “Coronary Arteriosclerosis”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Pamela Susan Douglas · Duke University$33,898,907
- Mark J Daly · Broad Institute, Inc.$29,637,180
- Stacey Gabriel · Massachusetts Institute Of Technology$29,637,180
- Robyn McClelland · University Of Washington$29,431,452
- Thomas None Quertermous · Stanford University$28,880,110
Research focus
Coronary ArteriosclerosisMorbidity - Disease RateCoronaryTransplant RecipientsArteriesTransplantationPressureBaseMeasurementRandomizedPharmaceutical PreparationsLeftPlacebosAnatomyAnterior Descending Coronary ArteryHigh RiskPhysiologicalPreventHeart AllograftHeart FailureArterial Fatty StreakCoronary AngiographyComplicationDouble-Blind Method
Grant awards (16)
Fractional flow reserve versus Angiography for Multivessel Evaluation (FAME) 3 Extended$769,846
R01 · FY2025 · HL · contact PI
PCSK9 Inhibition after Heart Transplantation$388,719
R33 · FY2023 · HL · contact PI
PCSK9 Inhibition after Heart Transplantation$443,451
R33 · FY2022 · HL · contact PI
PCSK9 Inhibition after Heart Transplantation$461,936
R33 · FY2021 · HL · contact PI
PCSK9 Inhibition after Heart Transplantation$461,936
R33 · FY2020 · HL · contact PI
PCSK9 Inhibition after Heart Transplantation$435,534
R61 · FY2019 · HL · contact PI
ACE Inhibition and Cardiac Allograft Vasculopathy$376,992
R01 · FY2013 · HL · contact PI
ACE Inhibition and Cardiac Allograft Vasculopathy$329,353
R01 · FY2012 · HL · contact PI
ACE Inhibition and Cardiac Allograft Vasculopathy$332,680
R01 · FY2011 · HL · contact PI
ACE Inhibition and Cardiac Allograft Vasculopathy$332,680
R01 · FY2010 · HL · contact PI
ACE Inhibition and Cardiac Allograft Vasculopathy$346,960
R01 · FY2009 · HL · contact PI
Invasive Assessment of the Coronary Microcirculation$125,962
K23 · FY2008 · HL · contact PI
Invasive Assessment of the Coronary Microcirculation$125,962
K23 · FY2007 · HL · contact PI
Invasive Assessment of the Coronary Microcirculation$125,962
K23 · FY2006 · HL · contact PI
Invasive Assessment of the Coronary Microcirculation$125,962
K23 · FY2005 · HL
Invasive Assessment of the Coronary Microcirculation$125,962
K23 · FY2004 · HL